Japan $26 Billion Medical Technology Giant Terumo to Buy UK Organ Preservation Device Leader OrganOx for $1.5 Billion, Founded in 2008 by Professor Peter Friend & Professor Constantin Coussios as Spin-off from University of Oxford
28th August | Hong Kong
Japan medical technology giant Terumo ($26 billion market value) has announced to buy UK organ preservation device leader OrganOx for $1.5 billion. OrganOx was founded in 2008 by Professor Peter Friend & Professor Constantin Coussios as a spin-off from University of Oxford. OrganOx – OrganOx is a commercial stage organ technology company, spun out of the University of Oxford in 2008, dedicated to developing technologies to improve outcomes for patients with acute or chronic organ failure. The OrganOx metra® is a normothermic machine perfusion (NMP) platform approved in the U.S., Europe, Canada, and Australia. It has been utilized in over 6,000 liver transplants to date to keep donor livers in a metabolically active state outside the body so that functional assessment of the organ can be performed prior to transplant, leading to an increased number of organs available for transplant. Learn more at www.organox.com. Terumo – Terumo (TSE: 4543) is a global leader in medical technology and has been committed to “Contributing to Society through Healthcare” for 100 years. Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.
“ Japan $26 Billion Medical Technology Giant Terumo to Buy UK Organ Preservation Device Leader OrganOx for $1.5 Billion, Founded in 2008 by Professor Peter Friend & Professor Constantin Coussios as Spin-off from University of Oxford “
![](https://www.caproasia.com/wp-content/uploads/2025/08/Air-Charter-Service-728x90-1.png")
Japan $26 Billion Medical Technology Giant Terumo to Buy UK Organ Preservation Device Leader OrganOx for $1.5 Billion, Founded in 2008 by Professor Peter Friend & Professor Constantin Coussios as Spin-off from University of Oxford
Caproasia Users
- Manage $20 million to $30 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 11,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2026 Investment Day
- March - Hong Kong
- March - Singapore
- April - Hong Kong
- April - Singapore
- July - Hong Kong
- July - Singapore
- Sept- Hong Kong
- Sept - Singapore
- Oct- Hong Kong
- Nov - Singapore
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Institutional Investor Summit
- The Investment / Alternatives Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit
